Department of Endocrinology, Oxford Centre for Diabetes, Endocrinology and Metabolism, Churchill Hospital, University of Oxford, Oxford, UK.
Clin Endocrinol (Oxf). 2011 Oct;75(4):501-4. doi: 10.1111/j.1365-2265.2011.04068.x.
The frequency of pituitary tumour regrowth after an episode of classical pituitary apoplexy is unknown. It is thus unclear whether regrowth, if it occurs, does so less frequently than with non-apoplectic non-functioning pituitary macroadenomas that have undergone surgery without postoperative irradiation. This has important repercussions on follow up protocols for these patients.
Retrospective cohort study of patients diagnosed with classical pituitary apoplexy in Oxford in the last 24 years.
MRI/CT scans of the pituitary were performed post-operatively and in those patients who did not receive pituitary irradiation, this was repeated yearly for 5 years and 2 yearly thereafter.
Thirty-two patients with non-functioning pituitary adenomas who presented with classical pituitary apoplexy were studied. There were 23 men and the mean age was 56·6 years (range 29-85). The mean follow up period was 81 months (range 6-248). Five patients received adjuvant radiotherapy within 6 months of surgery and were excluded from further analysis. In this group, there were no recurrences during a mean follow up of 83 months (range 20-150). In the remaining 27 cases there were 3 recurrences, with a mean of 79 months follow up (range 6-248) occurring 12, 51 and 86 months after surgery. This gives a recurrence rate of 11·1% at a mean follow up of 6·6 years post surgery. All recurrences had residual tumour on the post operative scan.
Patients with classical pituitary apoplexy may show recurrent pituitary tumour growth and therefore these patients need continued post-operative surveillance if they have not had post-operative radiotherapy.
在经历一次典型垂体卒中后,垂体肿瘤复发的频率尚不清楚。因此,尚不清楚肿瘤是否会再次生长,如果会的话,其复发频率是否低于未接受术后放疗的非卒中型无功能性垂体大腺瘤。这对这些患者的随访方案有重要影响。
在过去 24 年中,对在牛津被诊断为典型垂体卒中的患者进行回顾性队列研究。
术后对垂体进行 MRI/CT 扫描,如果患者未接受垂体放疗,则在 5 年内每年重复扫描一次,此后每 2 年重复扫描一次。
研究了 32 例表现为典型垂体卒中的无功能性垂体腺瘤患者。其中 23 例为男性,平均年龄为 56.6 岁(范围 29-85 岁)。平均随访时间为 81 个月(范围 6-248 个月)。5 例患者在术后 6 个月内接受了辅助放疗,因此被排除在进一步分析之外。在这一组中,在平均 83 个月(范围 20-150 个月)的随访中无复发。在其余 27 例中,有 3 例复发,平均随访时间为 79 个月(范围 6-248 个月),分别在术后 12、51 和 86 个月出现。这意味着在平均 6.6 年的术后随访中,复发率为 11.1%。所有的复发均在术后扫描中显示残留肿瘤。
患有典型垂体卒中的患者可能会出现垂体肿瘤的复发性生长,因此如果这些患者未接受术后放疗,则需要继续进行术后监测。